Skip to main content
Commonwealth of Virginia branding bar cardinal logo

Virginia.gov

A design prototype by Datopian, not an official website

Find a Commonwealth Resource

Trastuzumab

HealthData.Gov

Updated Oct 29, 2026

About this dataset

HERZUMA (trastuzumab) is a biosimilar medication used to treat certain breast cancers that are HER2-positive. It's administered intravenously as an injection in a 420 mg dose. Manufactured by Celltrion Inc., it's a HER2/neu receptor antagonist that helps block cancer cell growth. This information was generated using AI and is provided for informational and research purposes only.

Data and resources (1)

  • HTML

    Trastuzumab

    Access the FDA dataset for Trastuzumab — ANDA 761106 submitted by Mylan Institutional LLC

    Modified Apr 29, 2026

Prototype by Datopian · not an official government website · data from data.virginia.gov